Alvin Shih insider trades
Open-market stock purchases and sales by Alvin Shih, Director at Zevra Therapeutics, Inc, from SEC Form 4 filings since Jun 26, 2015.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +54%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 4, 2026 | ZVRA Zevra Therapeutics, Inc | Bought (not open market) | — |